Print

HVTN 044

A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of the HIV-1 DNA Vaccine VRC-HIVDNA009-00-VP (Gag-Pol-Nef-multiclade Env) With the Plasmid Cytokine Adjuvant VRC-ADJDNA004-IL2-VP (IL-2/Ig)

Trial Details:

I Completed
HIV Vaccine Trials Network (HVTN) December 01, 2003
VRC-HIVDNA009-00-VP gag B, gol B, nef B, env A, env B, env C
VRC-HIVDNA009-00-VP DNA
USA 70
NCT00069030
http://clinicaltrials.gov/show/NCT00069030